Mix of civil law and common law. Official law database Ministry for justice, culture and local government of Malta

Size: px
Start display at page:

Download "Mix of civil law and common law. Official law database Ministry for justice, culture and local government of Malta"

Transcription

1 Malta European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible. Where we link to unofficial sources this is noted and users should take this into account before relying on these materials. We recommend checking with the relevant national government if you have questions about the currency or validity of any unofficial source of law. Legal system Mix of civil law and common law National law database Language: Link: Nature: Organisation responsible for the website: Maltese and English Official law database Ministry for justice, culture and local government of Malta The health system and policy monitor: regulation (PDF) As part of its Health Systems in Transition (HiT) series the European Observatory on Health Systems and Policies systematically describes the functioning of health systems in countries as well as reform and policy initiatives in progress or under development. The HiT health system reviews cover the countries of the WHO European Region as well as some additional OECD countries. This PDF includes information about the country s regulation. To see the complete HiT report of this country go to:

2 Search list of contents: Regulation Overview and publication details Regulation Malta 2 3 Page 1/4

3 Regulation Malta HIT: Azzopardi Muscat N, Calleja N, Calleja A, Cylus J. HSPM Members: Department of Health Services Management, Faculty of Health Sciences, University of Malta HSPM Contributors: Azzopardi Muscat N, Buttigieg N, Grech K, Cylus J. Page 2/4

4 Malta - Regulation Malta: Regulation 2.8 Regulation Registration and planning of human resources Registration of health care professionals is regulated by the Health-Care Professions Act. The registration of all such professionals is under the responsibility of the Superintendent of Public Health. Professional regulators are responsible for granting of licences, and maintaining and updating professional registers for each health profession. They also monitor professional and ethical standards and carry out disciplinary proceedings. With regard to nursing and paramedical professions, due to concerns over the supply of workers there has been engagement between the health authorities and Faculty of Health Sciences. As a result the capacity of this Faculty s nursing course has been increased and a drive for the recruitment of foreign nurses organized. Every year, the Ministry for Health presents a consolidated business plan and a human resource plan based on the needs of all health facilities and departments. All capacity building is thereafter negotiated with the Ministry for Finance, as it is responsible for coordinating all public sector requests. Long-term human resource planning typically involves health authorities and education authorities collaborating with the University of Malta to decide which courses should be offered and at what frequency. Recently the government has embarked on the local provision of specialized training. In addition, there is the local foundation programme, which prepares newly graduated doctors for full registration with the Medical Council Regulation and governance of pharmacies Legislation specifies criteria for opening new pharmacies, as well as the standards to be maintained. Current legislation does not allow for Internet pharmacies. Pharmacies can only purchase medicines from authorized wholesale dealers. The supply chain is regulated to minimize the risk of counterfeit medicines entering the supply chain. However when patients do purchase medicines from unauthorized Internet pharmacies, these cannot be regulated. In addition to the information on specific products available through published pack leaflets and summaries of product characteristics, the Medicines Authority which is tasked with protecting and enhancing public health through the regulation of medicinal products and pharmaceutical activities makes available additional medicines information to empower patients and to support rational medicines use Regulation and governance of pharmaceuticals Medicinal products are regulated through a national legal framework presented in the Medicines Act, Chapter 458 of the Laws of Malta and its subsidiary legislation. Based on this Act, the Superintendent of Public Health is the Licensing Authority for all regulatory functions. The Licensing Authority delegates some functions related to licensing and surveillance of medicinal products and clinical trials to the Medicines Authority. All products are authorized in line with procedures as specified in European legislation. Post-authorization, all medicinal products on the local market are monitored for their quality and for their safety. The list of all authorized medicinal products and the approved package leaflet and the summary of product characteristics are published on the website of the Medicines Authority. All products placed on the market must be manufactured in EU Good Manufacturing Practice (EU-GMP) certified and authorized facilities; products imported directly from outside the EU must first be tested and batch released. EU-GMP certificates issued by the Medicines Authority are recognized by partner countries through a European Mutual Recognition Agreement. Standards of EU Good Distribution Practice are applied for wholesale distribution. Medicinal products can only be brought into Malta from the EU through EU authorized wholesale dealers. Each authorized wholesale dealer must retain a registered pharmacist, who is responsible for all technical aspects of the operations carried out by the wholesale dealer. Advertising of prescription medicines is not allowed, consistent with EU law. Only information approved in Page 3/4

5 Malta - Regulation the summary of product characteristics is allowed in advertisements of non-prescription items. Sale of pharmaceutical items is only permitted within pharmacies. Legislation stipulates that, unless a prescriber specifically requests the dispensing of an originator drug, pharmacists can do product substitution at the pharmacy level as long as the product dispensed has the same active ingredient, dose and same dosage form as that prescribed Regulation of medical devices and aids Medical devices are regulated by the Malta Competition and Consumer Affairs Authority, which forms part of the Ministry for Social Dialogue, Consumer Affairs and Civil Liberties. The legislation on medical devices is fully in line with the EU legislation Regulation of capital investment On the basis of advice from the Health Policy and Strategy Board, the Minister for Health approves recommendations for capital investments commensurate with published health strategies. Such capital proposals also require clearance from the Ministry for Finance. Following EU accession, Malta has also been able to access European funds, including the European Regional Development Fund. Capital projects are managed by the Foundation for Medical Services from project planning to execution and handed back to the Ministry once complete and operational. All public procurement follows EU public procurement regulations. Page 4/4

The Swedish national courts administration. data/assets/pdf_file/0020/96410/e73430.pdf

The Swedish national courts administration.  data/assets/pdf_file/0020/96410/e73430.pdf Sweden European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

Estonian ministry of justice. data/assets/pdf_file/0018/231516/hit-estonia.pdf

Estonian ministry of justice.  data/assets/pdf_file/0018/231516/hit-estonia.pdf Estonia European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

Hungary. European Region. Legal system. National law database. Legal UHC start date The health system and policy monitor: regulation (PDF)

Hungary. European Region. Legal system. National law database. Legal UHC start date The health system and policy monitor: regulation (PDF) Hungary European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

Official law database that combines 15 national databases Slovenian government office for legislation

Official law database that combines 15 national databases Slovenian government office for legislation Slovenia European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

Mix of civil law, common law, Jewish law and Islamic law

Mix of civil law, common law, Jewish law and Islamic law Israel European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

The office of the attorney general. data/assets/pdf_file/0004/85306/e92928.pdf

The office of the attorney general.  data/assets/pdf_file/0004/85306/e92928.pdf Ireland European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

Guidance for registered pharmacies preparing unlicensed medicines

Guidance for registered pharmacies preparing unlicensed medicines Guidance for registered pharmacies preparing unlicensed medicines May 2014 The text of this document (but not the logo and branding) may be reproduced free of charge in any format or medium, as long as

More information

data/assets/pdf_file/0010/107848/e68284.pdf

data/assets/pdf_file/0010/107848/e68284.pdf Portugal European Region Updated: February 2017 This document contains links to websites where you can find national legislation and health laws. We link to official government legal sources wherever possible.

More information

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services

International Pharmaceutical Federation Fédération internationale pharmaceutique. Standards for Quality of Pharmacy Services International Pharmaceutical Federation Fédération internationale pharmaceutique PO Box 84200, 2508 AE The Hague, The Netherlands Standards for Quality of Pharmacy Services Standards are an important part

More information

SFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use

SFHPHARM11 - SQA Unit Code FA2X 04 Prepare extemporaneous medicines for individual use Prepare extemporaneous medicines for individual use Overview This standard covers your role in preparing extemporaneous medicines for individual use. This involves accurately calculating the quantities

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SCHEDULING OF SUBSTANCES FOR PRESCRIBING BY AUTHORISED PRESCRIBERS This document provides guidance on the process for amending the Schedules to the Medicines and Related Substances

More information

Legislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018

Legislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018 Legislations and Policies in Jordan/ Related to Health and Pharmaceuticals April 19, 2018 Dr. Rania Bader, HRH2030 Health Workforce Competency Lead HRH2030 The Human Resources for Health (HRH2030) is a

More information

European Association of Hospital Pharmacists (EAHP)

European Association of Hospital Pharmacists (EAHP) European Association of Hospital Pharmacists (EAHP) Consultation Response Delegated Act on the detailed rules for a unique identifier for medicinal products for human use, and its verification. April 2012

More information

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division UK strategy for reclassification of medicines Dr Sarah Branch, Deputy Director, VRMM Division MHRA commitment to reclassification Reclassification of medicines to non-prescription when safe to do so and

More information

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy

Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Unlicensed medicines ( specials ) Current issues related to unlicensed medicines and a suggested approach to devising a coherent sourcing strategy Andrew Tittershill Content Personal introduction. Defining

More information

THE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016

THE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016 THE CODE Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland Effective from 1 March 2016 PRINCIPLE 1: ALWAYS PUT THE PATIENT FIRST PRINCIPLE 2: PROVIDE A SAFE

More information

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Zimbabwe

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Zimbabwe Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) This document is not a formal publication of WHO and does not necessarily represent the decisions

More information

DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE

DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE DANISH PHARMACONOMIST A PROFESSION WITH A PROFESSIONAL PROFILE BACKGROUND AND AIMS This project focuses on the core competences Danish pharmaconomists receive through their education and their work areas.

More information

Legal limitations for nurse prescribers: a focus on dispensing. Andy Gray Division of Pharmacology Discipline of Pharmaceutical Sciences

Legal limitations for nurse prescribers: a focus on dispensing. Andy Gray Division of Pharmacology Discipline of Pharmaceutical Sciences Legal limitations for nurse prescribers: a focus on dispensing Andy Gray Division of Pharmacology Discipline of Pharmaceutical Sciences Outline What is prescribing? What is dispensing? Enabling legal frameworks

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION GROUP OF EXPERTS ON PHARMACEUTICAL PRODUCTS Guide for health professionals concerning counterfeit drugs Bahamas - Brasil Lima,

More information

LIFE SCIENCES & HEALTHCARE IN UKRAINE

LIFE SCIENCES & HEALTHCARE IN UKRAINE LIFE SCIENCES & HEALTHCARE IN UKRAINE 2017 in Review January 2018 Gulliver Business Center 1-A, Sportyvna sq. Kyiv 01601, Ukraine Tel. (38) 044 394 9040 CONTENTS HEALTHCARE REFORM............................3

More information

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Botswana

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Botswana Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Botswana This document is not a formal publication of WHO and does not necessarily represent the

More information

Annexure A COMPETENCE STANDARDS FOR CPD INTRODUCTION

Annexure A COMPETENCE STANDARDS FOR CPD INTRODUCTION COMPETENCE STANDARDS FOR CPD INTRODUCTION Pharmacists in each field of practice need to accept responsibility for the selfassessment and maintenance of their competence throughout their professional lives.

More information

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) ANGOLA

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) ANGOLA Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) ANGOLA 1 Outline of the Profile Introduction p. 3 Part 1- Health and Demographic Data.. p. 4 Part

More information

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist Curriculum vitae PERSONAL INFORMATION Gyorgyi Fodor WORK EXPERIENCE September 2011 Present Pharmacovigilance assessor National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Benefit/risk assessment,

More information

NATIONAL MEDICINAL PRODUCTS POLICY 2013

NATIONAL MEDICINAL PRODUCTS POLICY 2013 THE NATIONAL MEDICINAL PRODUCTS POLICY OF THE REPUBLIC OF FIJI 2013 2 NATIONAL MEDICINAL PRODUCTS POLICY 2013 FOREWORD Medicines are required for prevention, control and treatment of illness. When a medicine

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SECTION 21 APPLICATION FORM Only to be used for orthodox/allopathic medicines for human use. 1. Fax completed form (i.e. pages 1-10), proof of payment of application fee (if applicable)

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

Annual Work Programme 2018

Annual Work Programme 2018 Annual Work Programme 2018 Infoday 30 January 2018 Irène ATHANASSOUDIS DG SANTE C1 The Health Programme Regulation EU N 282/2014 of 11 March 2014 Promoting health Encouraging innovation in health Complement,

More information

KINGDOM OF CAMBODIA Nation Religion King

KINGDOM OF CAMBODIA Nation Religion King (Logo) Ministry of Health KINGDOM OF CAMBODIA Nation Religion King Unofficial Translation No. 0014 អបស/ឱអបស Phnom Penh Capital, January 13, 2009 PRAKAS On the Modification to Prakas No. 155 អបស/ឱអបស Dated

More information

External Assessment Specifications Document

External Assessment Specifications Document External Assessment Specifications Document Curriculum Code: 321301000 Qualification Title: Occupational Certificate: Pharmacy Technician NQF Level: 6 321301000 - Pharmacy Technician External Assessment

More information

HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce

HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce HCA 302 Module 5 Lecture Notes The Pharmaceutical Industry and Health Care Workforce Why are pharmaceuticals important? The Pharmaceutical Industry has influence, in part because it represents 10% of the

More information

Nanjing Statements. Statements on Pharmacy and Pharmaceutical Sciences Education. Copyright 2017 International Pharmaceutical Federation (FIP)

Nanjing Statements. Statements on Pharmacy and Pharmaceutical Sciences Education. Copyright 2017 International Pharmaceutical Federation (FIP) Nanjing Statements Statements on Pharmacy and Pharmaceutical Sciences Education 2017 Copyright 2017 International Pharmaceutical Federation (FIP) The Nanjing Statements on Pharmacy and Pharmaceutical Sciences

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:

More information

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business

Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business to facilitate compliance with Regulation 12 of the Regulation of Retail Pharmacy Businesses

More information

Introducing a new CPD system for pharmacists in Ireland

Introducing a new CPD system for pharmacists in Ireland Introducing a new CPD system for pharmacists in Ireland Dr. Lorraine Horgan Head of Professional Development & Learning, PSI European Commission Workshop Brussels, 11 February 2016 Outline Role of the

More information

Following are some common questions and answers from the hospital perspective regarding Manufacturing and Compounding :

Following are some common questions and answers from the hospital perspective regarding Manufacturing and Compounding : Health Canada Manufacturing and Compounding Drug Products in Canada: A Policy Framework : Guidelines for P.E.I. Community and Hospital Pharmacists October 2001 In response to pharmacists questions about

More information

Good Governance for Medicines Medicines as part of Universal Health Coverage

Good Governance for Medicines Medicines as part of Universal Health Coverage Good Governance for Medicines Medicines as part of Universal Health Coverage Gilles Forte World Health Organization Department of Essential Medicines and Health Products Geneva 1 Substantial budgets are

More information

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

AN ACT. Be it enacted by the General Assembly of the State of Ohio: (131st General Assembly) (Substitute House Bill Number 124) AN ACT To amend section 4729.01 and to enact sections 4723.4810, 4729.282, 4730.432, and 4731.93 of the Revised Code regarding the authority

More information

Improving compliance with oral methotrexate guidelines. Action for the NHS

Improving compliance with oral methotrexate guidelines. Action for the NHS Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Who Should Read This Policy Target Audience All Consultant/Senior Medical Staff All Junior Medical Staff All Non-Medical Prescribers All Pharmacy Staff All Nursing Staff Version 1.0 February 2016 Ref.

More information

NAMIBIA MEDICINES REGULATORY COUNCIL MINISTRY OF HEALTH AND SOCIAL SERVICES

NAMIBIA MEDICINES REGULATORY COUNCIL MINISTRY OF HEALTH AND SOCIAL SERVICES 1 NAMIBIA MEDICINES REGULATORY COUNCIL MINISTRY OF HEALTH AND SOCIAL SERVICES FEES PAYABLE TO THE REGISTRAR (Regulation 47) 1. In respect of an application for registration of a Category A medicine - (a)

More information

Good Practice Principles:

Good Practice Principles: NHMC National Homecare Medicines Committee Good Practice Principles: Provision of Manufacturer Funded Homecare Medicines Services National Homecare Medicines Committee February 2018 Version 1 Definitions

More information

Teamwork in healthcare organisations

Teamwork in healthcare organisations Pharmacy Education, Month 2005; 00(0): 1 7 Teamwork in healthcare organisations M. GAFÀ 1, A. FENECH 2, C. SCERRI 2, & D. PRICE 3 1 Primary Healthcare Department, Ministry of Health, Paola Government Dispensary,

More information

Foundation Pharmacy Framework

Foundation Pharmacy Framework Association of Pharmacy Technicians UK Foundation Pharmacy Framework A framework for professional development in foundation across pharmacy APTUK Foundation Pharmacy Framework The Professional Leadership

More information

Responsible pharmacist requirements: What activities can be undertaken?

Responsible pharmacist requirements: What activities can be undertaken? requirements: What activities can be undertaken? Status of this document This guidance is intended to assist the profession in implementing the responsible requirements within registered premises. 1 Appendix

More information

ZAMBIA MEDICINES REGULATORY AUTHORITY EMPLOYMENT OPPORTUNITY

ZAMBIA MEDICINES REGULATORY AUTHORITY EMPLOYMENT OPPORTUNITY ZAMBIA MEDICINES REGULATORY AUTHORITY EMPLOYMENT OPPORTUNITY The Zambia Medicines Regulatory Authority (ZAMRA) was set up by the Medicines and Allied Substances Act (No. 3) of 2013 as a statutory body

More information

Good Pharmacy Practice in Spanish Community Pharmacy

Good Pharmacy Practice in Spanish Community Pharmacy GENERAL PHARMACEUTICAL COUNCIL OF SPAIN Good Pharmacy Practice in Spanish Community Pharmacy 01 Dispensing Service for Medicines and Medical Devices This document has been developed by the Good Pharmacy

More information

Registration of a new pharmacy premises

Registration of a new pharmacy premises Registration of a new pharmacy premises Send your completed application to: Pharmacy premises Applications to Register Customer Service Team General Pharmaceutical Council 25 Canada Square London E14 5LQ

More information

Council of the European Union Brussels, 24 February 2015 (OR. en)

Council of the European Union Brussels, 24 February 2015 (OR. en) Council of the European Union Brussels, 24 February 2015 (OR. en) 6527/15 SAN 52 SOC 96 OUTCOME OF PROCEEDINGS From: General Secretariat of the Council To: Delegations Subject: Working Party on Public

More information

The European network evaluation of the PHAR QA framework of competences for...

The European network evaluation of the PHAR QA framework of competences for... The European network evaluation of the PHAR QA framework of competences for... The PHAR QA ( Quality assurance in European pharmacy education and training ) funded by the European Commission, will produce

More information

NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets.

NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets. NCCP Guidance on the Retention and Disposal of Systemic Anti-Cancer Therapy (SACT) prescriptions and compounding worksheets. Version Date Amendment Approved By 1 11/01/2017 Version 1 NCCP following consultation

More information

PHARMACITS COUNCIL OF NIGERIA ACT (1992 No. 91) REGISTRATION OF PHARMACEUTICAL PREMISES REGULATIONS, 2005.

PHARMACITS COUNCIL OF NIGERIA ACT (1992 No. 91) REGISTRATION OF PHARMACEUTICAL PREMISES REGULATIONS, 2005. S. I. 14 of 2005 B153 PHARMACITS COUNCIL OF NIGERIA ACT (1992 No. 91) REGISTRATION OF PHARMACEUTICAL PREMISES REGULATIONS, 2005. Commencement: 26th July, 2005 In exercise of the powers conferred upon the

More information

Canada s Multi-Stakeholder Approach to Drug Shortages

Canada s Multi-Stakeholder Approach to Drug Shortages Canada s Multi-Stakeholder Approach to Drug Shortages Health Canada Presentation to the Canadian Agency For Drugs And Technologies In Health April X, 2017 Overview Context A Collaborative Multi-Stakeholder

More information

PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT)

PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT) AC ANNEX 1 & 2 PHARMACEUTICAL SOCIETY OF SINGAPORE (PSS) CERTIFIED PHARMACY TECHNICIAN COURSE WSQ ADVANCED CERTIFICATE IN HEALTHCARE SUPPORT (PHARMACY SUPPORT) Pharmaceutical Society of Singapore Alumni

More information

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package...

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package... Table Of Content Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package... 8 Coordination and evaluation of the project... 8 Structured

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information

Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information SECOND SESSION THIRTY-NINTH LEGISLATURE Bill 59 (2012, chapter 23) An Act respecting the sharing of certain health information Introduced 29 February 2012 Passed in principle 29 May 2012 Passed 15 June

More information

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country? Patient Safety p.1 Submission: 82 Name of organisation Mater Dei Hospital, Pathology Labs, MALTA Stakeholder group Member States authority Country MALTA Address Mater Dei Hospital, Tal- Qroqq, MSD 2090

More information

Therefore the provision of medicines is an area for which a Community regulatory framework should be properly supervised to ensure full and

Therefore the provision of medicines is an area for which a Community regulatory framework should be properly supervised to ensure full and European Association of Pharmaceutical Full-line Wholesalers (GIRP) response to the European Commission Consultation regarding Community action on Health Services Introduction Firstly, GIRP welcomes the

More information

REGISTRATION OF MEDICINES IN THE EURASIAN ECONOMIC UNION

REGISTRATION OF MEDICINES IN THE EURASIAN ECONOMIC UNION REGISTRATION OF MEDICINES IN THE EURASIAN ECONOMIC UNION www.gratanet.com At the Pharmaceutical Forum of the EAEU and CIS countries held in Moscow in late February 2018, the Director of the Department

More information

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7

More information

European Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state

European Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state European Commission consultation on measures for improving the recognition of medical prescriptions issued in another member state NHS European Office response The National Health Service (NHS) is one

More information

D DRUG DISTRIBUTION SYSTEMS

D DRUG DISTRIBUTION SYSTEMS D DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Drug distribution systems in the hospital setting should ideally prevent medication errors from occurring. When errors do occur, the system

More information

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Malawi

Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Malawi Country Data Profile on the Pharmaceutical Situation in the Southern African Development Community (SADC) Malawi This document is not a formal publication of WHO and does not necessarily represent the

More information

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy

More information

Responsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare

Responsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare Responsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare INTRODUCTION This summary provides - an evaluation

More information

The South African Pharmacy Council An introduction to our Legal Team

The South African Pharmacy Council An introduction to our Legal Team The South African Pharmacy Council An introduction to our Legal Team FMU Investigator Indaba 1 & 2 November 2010 D. Hoffmann & T Boase 1 INTRODUCTION TO THE SOUTH AFRICAN PHARMACY COUNCIL The South African

More information

Statutory Instrument 2003 No. 1590

Statutory Instrument 2003 No. 1590 Statutory Instrument 2003 No. 1590 The Health Professions Order 2001 (Consequential Amendments) Order 2003 Crown Copyright 2003 STATUTORY INSTRUMENTS 2003 No. 1590 HEALTH CARE AND ASSOCIATED PROFESSIONS

More information

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations Luc Hessel M.D. European Vaccine Manufacturers vm-vaccines.org www.evm-vaccines.org www.evm-vaccines.org

More information

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION This joint statement was developed by the CMA and the Canadian Pharmaceutical

More information

Dear Colleague. November 2013

Dear Colleague. November 2013 NHS Circular: PCA (P) (2013) 29 ehealth, Finance & Pharmaceutical Directorate Pharmacy & Medicines Division Dear Colleague ADDITIONAL PHARMACEUTICAL SERVICES INTRODUCTION OF GLUTEN FREE FOOD SERVICE TIMETABLE,

More information

High level guidance to support a shared view of quality in general practice

High level guidance to support a shared view of quality in general practice Regulation of General Practice Programme Board High level guidance to support a shared view of quality in general practice March 2018 Publications Gateway Reference: 07811 This document was produced with

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS

LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS Joey Gouws MCC and Cluster: Food Control, Pharmaceutical Trade and Product Regulation NATIONAL DEPARTMENT OF HEALTH

More information

Health Publications 2009 from TSO

Health Publications 2009 from TSO Health Publications 2009 from TSO British Pharmacopoeia The authoritative collection of standards for UK medicines The British Pharmacopoeia 2010 British Pharmacopoeia Commission The British Pharmacopoeia

More information

High Level Pharmaceutical Forum

High Level Pharmaceutical Forum High Level Pharmaceutical Forum 2005-2008 Final Conclusions and Recommendations of the High Level Pharmaceutical Forum On 2 nd October 2008, the High Level Pharmaceutical Forum agreed on the following

More information

Prescription Monitoring Program State Profiles - California

Prescription Monitoring Program State Profiles - California Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control

More information

Study definition of CPD

Study definition of CPD 1. ABSTRACT There is widespread recognition of the importance of continuous professional development (CPD) and life-long learning (LLL) of health professionals. CPD and LLL help to ensure that professional

More information

Medication Management and Use. Anadolu Medical Center. August, Departman Tarih

Medication Management and Use. Anadolu Medical Center. August, Departman Tarih Medication Management and Use Anadolu Medical Center August, 2014 Departman Tarih Medication Management and Use standards (MMU) Organization and Management 1. Medication use in the hospital is organized

More information

PRESCRIBING SUPPORT TECHNICIAN:

PRESCRIBING SUPPORT TECHNICIAN: PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin

More information

COMPLIANCE. in a Pharmaceutical Industry Perspective. Copenhagen Compliance and Concordance Conference 30th May 2008

COMPLIANCE. in a Pharmaceutical Industry Perspective. Copenhagen Compliance and Concordance Conference 30th May 2008 COMPLIANCE in a Pharmaceutical Industry Perspective Copenhagen Compliance and Concordance Conference 30th May 2008 Alejandra Mørk, M.Sc.Pharm., Ph.D, CEO KLIFO A/S Why is Compliance an issue? A succes

More information

Automated Dose Dispensing (ADD) Guidelines:. Best Practice for the ADD Process, and Care and Safety of Patients

Automated Dose Dispensing (ADD) Guidelines:. Best Practice for the ADD Process, and Care and Safety of Patients Automated Dose Dispensing (ADD) Guidelines:. Best Practice for the ADD Process, and Care and Safety of Patients Deadline for comments: 24 February 2017 Comments should be sent to ADD@edqm.eu The purpose

More information

Best Practice Statement ~ March Patient Group Directions

Best Practice Statement ~ March Patient Group Directions Best Practice Statement ~ March 2006 Patient Group Directions NHS Quality Improvement Scotland 2005 ISBN 1-84404-403-3 First published March 2006 NHS Quality Improvement Scotland (NHS QIS) consents to

More information

Health Profession Councils National Strategic Plan

Health Profession Councils National Strategic Plan KINGDOM OF CAMBODIA NATION RELIGION KING Health Profession Councils National Strategic Plan 2015 2020 JUNE 2015 Supported by Health Profession Councils National Strategic Plan 2015 2020 DISCLAIMER This

More information

Quality Medication Use in Aboriginal Communities

Quality Medication Use in Aboriginal Communities Quality Medication Use in Aboriginal Communities Lance Emerson, Kathy Bell, Roland Manning 5th National Rural Health Conference Adelaide, South Australia, 14-17th March 1999 Lance Emerson Proceedings Quality

More information

UHNS Hospital Pharmacy Service and Hot Topics. Sue Thomson Clinical Director of Pharmacy and Medicines Optimisation

UHNS Hospital Pharmacy Service and Hot Topics. Sue Thomson Clinical Director of Pharmacy and Medicines Optimisation UHNS Hospital Pharmacy Service and Hot Topics Sue Thomson Clinical Director of Pharmacy and Medicines Optimisation 1,200 beds Cancer Centre status Trauma Centre Cystic Fibrosis centre Tertiary referral

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL SA GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINES This document is intended to serve as guidance on the requirements for Good Manufacturing Practice in South Africa. This

More information

NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF

NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF NHS Fife WORKING WITH THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE EQUIPMENT SUPPLIERS GUIDANCE FOR NHS STAFF This guidance relates to all staff employed by NHS Fife (including staff within the Health &

More information

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED

More information

EU/ACP/WHO RENEWED PARTNERSHIP

EU/ACP/WHO RENEWED PARTNERSHIP EU/ACP/WHO RENEWED PARTNERSHIP Strengthening pharmaceutical systems and improving access to quality medicines ETHIOPIA 2012 2016 ABOUT THE RENEWED PARTNERSHIP IN ETHIOPIA The Ethiopian segment of the Renewed

More information

US Compounding 2515 College Ave Conway, AR (800)

US Compounding 2515 College Ave Conway, AR (800) PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy

More information

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead: Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of

More information

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country? Patient Safety p.1 Submission: 163 Stakeholder group Other other, please specify Hospital Country Germany Role in organisation management Number of employees 250 - Your organisation's geographical area

More information

CHAPTER 29 PHARMACY TECHNICIANS

CHAPTER 29 PHARMACY TECHNICIANS CHAPTER 29 PHARMACY TECHNICIANS 29.1 HOSPITAL PHARMACY TECHNICIANS 1. Proper Identification as Pharmacy Technician 2. Policy and procedures regulating duties of technician and scope of responsibility 3.

More information

AD HOC GROUP ON COUNTERFEIT MEDICINES (P-SP-PH/CMED)

AD HOC GROUP ON COUNTERFEIT MEDICINES (P-SP-PH/CMED) Page 1 of 6 AD HOC GROUP ON COUNTERFEIT MEDICINES (P-SP-PH/CMED) NATIONAL AND INTERNATIONAL CO-OPERATION TO COMBAT COUNTERFEITING OF MEDICINES AND PHARMACEUTICAL CRIMES: A MODEL FOR A NETWORK AND SINGLE

More information

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration

More information

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014 FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014 1.0.0 DOMAIN 1 - FOUNDATIONAL KNOWLEDGE 1.1.0 Learner (Learner) Apply knowledge from the foundational sciences (i.e., pharmaceutical,

More information